Cheryl D. Schwartz

625 total citations
12 papers, 460 citations indexed

About

Cheryl D. Schwartz is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Cheryl D. Schwartz has authored 12 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Cheryl D. Schwartz's work include Melanoma and MAPK Pathways (5 papers), Synthesis and biological activity (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Cheryl D. Schwartz is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Synthesis and biological activity (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Cheryl D. Schwartz collaborates with scholars based in United States and Japan. Cheryl D. Schwartz's co-authors include Stephen J. O’Keefe, James B. Doherty, Dennis M. Zaller, Suresh B. Singh, Dennis M. Schmatz, Meng‐Hsin Chen, Luping Liu, S. Natarajan, Catherine E. Fitzgerald and Edward A. O’Neill and has published in prestigious journals such as Endocrinology, Bioorganic & Medicinal Chemistry Letters and The Journal of Antibiotics.

In The Last Decade

Cheryl D. Schwartz

12 papers receiving 443 citations

Peers

Countries citing papers authored by Cheryl D. Schwartz

Since Specialization

Citations

This map shows the geographic impact of Cheryl D. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl D. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl D. Schwartz more than expected).

Fields of papers citing papers by Cheryl D. Schwartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl D. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl D. Schwartz. The network helps show where Cheryl D. Schwartz may publish in the future.

Co-authorship network of co-authors of Cheryl D. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl D. Schwartz. A scholar is included among the top collaborators of Cheryl D. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl D. Schwartz. Cheryl D. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Meng‐Hsin Chen, (unknown), Suresh B. Singh, Edward A. O’Neill, Cheryl D. Schwartz, Chris M. Thompson, Stephen J. O’Keefe, Dennis M. Zaller, James B. Doherty	38
2	Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Luping Liu, Sangita B. Patel, James V. Pivnichny, Giovanna Scapin, Suresh B. Singh, Cornelis E. C. A. Hop, Zhen Wang, John R. Strauss, Patricia M. Cameron, E.A. Nichols, Stephen J. O’Keefe, Edward A. O’Neill, Dennis M. Schmatz, Cheryl D. Schwartz, Chris M. Thompson, Dennis M. Zaller, James B. Doherty	66
3	SAR of 3,4-Dihydropyrido[3,2-d]pyrimidone p38 inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Luping Liu, (unknown), S. Natarajan, Meng‐Hsin Chen, Suresh B. Singh, Cheryl D. Schwartz, Catherine E. Fitzgerald, Stephen J. O’Keefe, Dennis M. Zaller, Dennis M. Schmatz, James B. Doherty	102
4	p38MAP kinase inhibitors. part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold 2003 ·Bioorganic & Medicinal Chemistry Letters ·S. Natarajan, David D. Wisnoski, Suresh B. Singh, (unknown), Edward A. O’Neill, Cheryl D. Schwartz, Chris M. Thompson, Catherine E. Fitzgerald, Stephen J. O’Keefe, Sanjeev Kumar, Cornelis E. C. A. Hop, Dennis M. Zaller, Dennis M. Schmatz, James B. Doherty	32
5	Pyridazine based inhibitors of p38 MAPK 2002 ·Bioorganic & Medicinal Chemistry Letters ·Charles McIntyre, G. S. PONTICELLO, Nigel J. Liverton, Stephen J. O’Keefe, Edward A. O’Neill, (unknown), Cheryl D. Schwartz, David A. Claremon	15
6	Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolate 1999 ·Bioorganic & Medicinal Chemistry Letters ·A. Brian Jones, John J. Acton, (unknown), Richard Cummings, Rose M. Cubbon, E.A. Nichols, Cheryl D. Schwartz, Linda S. Wicker, Jeffrey D. Hermes	3
7	Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligands 1999 ·Bioorganic & Medicinal Chemistry Letters ·A. Brian Jones, John J. Acton, Alan D. Adams, (unknown), E.A. Nichols, Cheryl D. Schwartz, Linda S. Wicker, Jeffrey D. Hermes	3
8	SAR for MHC class II binding tetrapeptides: Correlation with potential binding site 1997 ·Bioorganic & Medicinal Chemistry Letters ·Barry R. Cunningham, (unknown), Richard L. Tolman, (unknown), E.A. Nichols, Cheryl D. Schwartz, Linda S. Wicker, Jeffrey D. Hermes, A. Brian Jones	6
9	L-156,602, a C5a antagonist with a novel cyclic hexadepsipeptide structure from Streptomyces sp. MA6348. Fermentation, isolation and structure determination. 1991 ·The Journal of Antibiotics ·Otto D. Hensens, Robert P. Borris, Lawrence R. Koupal, Charles G. Caldwell, Sara Currie, (unknown), Carl F. Homnick, (unknown), (unknown), Cheryl D. Schwartz, (unknown), H. B. Woodruff, Deborah L. Zink, LAURETTA ZITANO, (unknown), Thomas E. Rollins, Martin S. Springer, James P. Springer	42
10	Novel and potent gastrin and brain cholecystokinin antagonists from Streptomyces olivaceus. Taxonomy, fermentation, isolation, chemical conversions, and physico-chemical and biochemical properties. 1991 ·The Journal of Antibiotics ·(unknown), Debra L. Bogen, Raymond S.L. Chang, (unknown), Otto D. Hensens, Deborah L. Zink, Cheryl D. Schwartz, (unknown), George M Garrity, (unknown), Sara Currie, H. B. Woodruff	22
11	A Structurally Unique, Potent, and Selective Oxytocin Antagonist Derived from Streptomyces silvensis 1989 ·Endocrinology ·Douglas J. Pettibone, Bradley V. Clineschmidt, Paul Anderson, Roger Freidinger, G. F. Lundell, Lawrence R. Koupal, Cheryl D. Schwartz, Joanne M. Williamson, Michael Goetz, Otto D. Hensens, Jerrold M. Liesch, James P. Springer	52
12	Difficidin and oxydifficidin: Novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis. I.Production, taxonomy and antibacterial activity. 1987 ·The Journal of Antibiotics ·S. B. Zimmerman, Cheryl D. Schwartz, Richard L. Monaghan, Barbara A. Pelak, (unknown), (unknown), S. Mochales, Sebastian Hernandez, Sara Currie, (unknown), E. O. Stapley	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact